Treatment of Mild Vascular Cognitive Impairment With Yangxue Qingnao Pill
Status:
Completed
Trial end date:
2018-03-31
Target enrollment:
Participant gender:
Summary
In this study, the effectiveness of vascular cognitive impairment was compared among the
three groups, namely, the xidezhen group, the Yangxue Qingnao pill group and the placebo
group